Skip to main content
RecallFDAfda-F-2320-2017UNDECLARED ALLERGEN

Denali "Original" Moose Tracks Cheesecake, Net Wt. 18 oz (510g). Black plastic base with clear plastic dome. Back label includes nutrit...

Category
Units Affected
425
Recall Date
May 9, 2017
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2320-2017.

Cheesecake has incorrect rear label. The rear label is for Pumpkin Swirl Cheesecake which lacks peanut allergen declaration.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2320-2017.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact The Father's Table, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2320-2017.

The Father's Table, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

The Father's Table, Llc Recall FAQ

The Father's Table, Llc is the subject of a dairy safety report: Denali "Original" Moose Tracks Cheesecake, Net Wt. 18 oz (510g). Black plastic base with clear plastic dome. Back label includes nutrit.... The notice was published on May 9, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 425 units are potentially affected.